Literature DB >> 31188435

Persistently Elevated PTH After Parathyroidectomy at One Year: Experience in a Tertiary Referral Center.

Marie Caldwell1, Jeff Laux2, Marshall Clark2, Lawrence Kim3, Janet Rubin1.   

Abstract

CONTEXT/
OBJECTIVE: Increased PTH after successful parathyroid surgery represents a clinical conundrum. We aimed to determine the prevalence of persistently elevated PTH (PePTH) postsurgery, along with predisposing factors.
DESIGN: and Setting: Patients ≥ age 18 with parathyroidectomy performed at University of North Carolina Hospitals for primary hyperparathyroidism (PHPT) over a 12-year period were identified from the Carolina Data Warehouse. Clinical and demographic characteristics were collected, transformed, and analyzed.
RESULTS: Five hundred seventy patients met initial criteria for PHPT, and of those 407 had postoperative values. One hundred forty-four had laboratory results within 3 to 18 months post operatively. There was no clinical difference between those with and without long-term laboratory follow-up. Presurgery, patients had average calcium of 11 mg/dL and PTH 125.4 pg/mL. Ninety-seven percent of patients had normalized calcium after surgery, but 30% had PePTH, which can be predicted at 3 months. Patients with PePTH (persistent elevation of PTH) after surgery did not differ from those with normalized PTH in terms of sex, age, body mass index, or excised gland weight; presurgery 25-vitamin D was slightly lower, but not abnormal (26 ± 15 vs 36 ± 11). The presurgical PTH was significantly higher (P < 0.001) in those with PePTH (156.5 pg/mL compared with presurgical level of 102.5 in those whose PTH normalized).
CONCLUSIONS: Nearly one-third of PHPT patients have elevated PTH levels postsurgery in a tertiary hospital setting. At presentation, patients with PePTH tend to have higher PTH relative to calcium levels. Whether PePTH after surgical treatment of PHPT has pathological consequences is unknown.
Copyright © 2019 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31188435      PMCID: PMC6736213          DOI: 10.1210/jc.2019-00705

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  26 in total

1.  Normocalcemia with elevated parathyroid hormone levels after surgical treatment of primary hyperparathyroidism.

Authors:  A Denizot; M Pucini; C Chagnaud; G Botti; J F Henry
Journal:  Am J Surg       Date:  2001-07       Impact factor: 2.565

2.  Worldwide trends in the surgical treatment of primary hyperparathyroidism in the era of minimally invasive parathyroidectomy.

Authors:  Wendy R Sackett; Bruce Barraclough; Tom S Reeve; Leigh W Delbridge
Journal:  Arch Surg       Date:  2002-09

3.  Reelevation of parathyroid hormone level after parathyroidectomy in patients with primary hyperparathyroidism: importance of decreased renal parathyroid hormone sensitivity.

Authors:  Hiroyuki Yamashita; Shiro Noguchi; Taiki Moriyama; Yuji Takamatsu; Kyoko Sadanaga; Shinya Uchino; Shin Watanabe; Takahiro Ogawa
Journal:  Surgery       Date:  2005-04       Impact factor: 3.982

4.  25-hydroxyvitamin D deficiency is a risk factor for symptoms of postoperative hypocalcemia and secondary hyperparathyroidism after minimally invasive parathyroidectomy.

Authors:  Zoe A Stewart; Amanda Blackford; Helina Somervell; Kent Friedman; Elizabeth Garrett-Mayer; Alan P B Dackiw; Martha A Zeiger
Journal:  Surgery       Date:  2005-12       Impact factor: 3.982

5.  Normalization of 2-week postoperative parathyroid hormone values in patients with primary hyperparathyroidism: four-gland exploration compared to focused-approach surgery.

Authors:  Peter J Mazzaglia; Mira Milas; Eren Berber; Alan Siperstein; Jack M Monchik
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

6.  Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience.

Authors:  Clive S Grant; Geoffrey Thompson; David Farley; Jon van Heerden
Journal:  Arch Surg       Date:  2005-05

7.  Postoperative elevated serum levels of intact parathyroid hormone after surgery for parathyroid adenoma: sign of bone remineralization and decreased calcium absorption.

Authors:  J Westerdahl; S Valdemarsson; P Lindblom; A Bergenfelz
Journal:  World J Surg       Date:  2000-11       Impact factor: 3.352

8.  Elevated serum parathormone level after "concise parathyroidectomy" for primary sporadic hyperparathyroidism.

Authors:  Sally E Carty; Michelle M Roberts; Mohamed A Virji; Laura Haywood; John H Yim
Journal:  Surgery       Date:  2002-12       Impact factor: 3.982

9.  Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism.

Authors:  Todd D Beyer; Carmen C Solorzano; Richard A Prinz; Ambika Babu; Naris Nilubol; Subhash Patel
Journal:  Surgery       Date:  2007-04-26       Impact factor: 3.982

10.  Long-term follow-up of patients with elevated PTH levels following successful exploration for primary hyperparathyroidism.

Authors:  E Nordenström; Johan Westerdahl; A Bergenfelz
Journal:  World J Surg       Date:  2004-06       Impact factor: 3.352

View more
  5 in total

1.  68Ga-DOTA-FAPI-04 PET mimicking whole body bone scan in a patient with metabolic bone disease.

Authors:  Chunxia Qin; Yangmeihui Song; Xiang Hu; Tianshu Zeng; Xiaoli Lan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06-14       Impact factor: 9.236

2.  Multiglandular Parathyroid Disease in Primary Hyperparathyroidism With Inconclusive Conventional Imaging.

Authors:  K Zajíčková; J Včelák; Z Lešková; M Grega; D Goltzman; D Zogala
Journal:  Physiol Res       Date:  2022-04-11       Impact factor: 2.139

3.  Ectopic Parathyroid Adenoma in an 11-Year-Old Girl: Case Report and Literature Review.

Authors:  Myrto Eleni Flokas; Gulnigor Ganieva; Amanda Grieco; Levon Agdere
Journal:  AACE Clin Case Rep       Date:  2020-11-28

4.  European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy: Recommendations of the ESE Educational Program of Parathyroid Disorders.

Authors:  Jens Bollerslev; Lars Rejnmark; Alexandra Zahn; Ansgar Heck; N M Appelman-Dijkstra; Luis Cardoso; Fadil M Hannan; Filomena Cetani; Tanja Sikjær; Anna Maria Formenti; Sigridur Björnsdottir; Camilla Schalin-Jantti; Zhanna Belaya; Fraser Wilson Gibb; Bruno Lapauw; Karin Amrein; Corinna Wicke; Corinna Grasemann; Michael Krebs; Eeva M Ryhänen; Ozer Makay; Salvatore Minisola; Sebastien Gaujoux; Jean-Philippe Bertocchio; Zaki K Hassan-Smith; Agnès Linglart; Elizabeth M Winter; Martina Kollmann; Hans-Georg Zmierczak; Elena Tsourdi; Stefan Pilz; Heide Siggelkow; Neil J Gittoes; Claudio Marcocci; Peter Kamenicky
Journal:  Eur J Endocrinol       Date:  2022-01-13       Impact factor: 6.664

5.  Bone Turnover Markers in Response to Ultrasound-Guided Microwave Ablation for Primary Hyperparathyroidism.

Authors:  Wenjing Ni; Yue Yuan; Xiaoqiu Chu; Guofang Chen; Xue Han; Jie Li; Xinping Wu; Jianhua Wang; Chao Liu; Shuhang Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-01       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.